In vivo penetration of antibiotics into sputum in cystic fibrosis.
D000111:Acetylcysteine / Q000494:pharmacology; D000336:Aerosols; D000667:Ampicillin / Q000032:analysis / Q000097:blood; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000032:analysis* / Q000097:blood; D001681:Biological Assay; D002509:Cephaloridine / Q000032:analysis / Q000097:blood; D003023:Cloxacillin / Q000032:analysis / Q000097:blood; D003550:Cystic Fibrosis / Q000150:complications / Q000188:drug therapy*; D004917:Erythromycin / Q000032:analysis / Q000097:blood; D005839:Gentamicins / Q000032:analysis / Q000097:blood; D006801:Humans; D017053:Infection Control; D008034:Lincomycin / Q000032:analysis / Q000097:blood; D008712:Methicillin / Q000032:analysis / Q000097:blood; D008970:Molecular Weight; D009675:Novobiocin / Q000032:analysis / Q000097:blood; D013183:Sputum / Q000032:analysis*; D013449:Sulfonamides / Q000032:analysis / Q000097:blood
D000336:Aerosols; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D013449:Sulfonamides; D009675:Novobiocin; D004917:Erythromycin; D000667:Ampicillin; D008034:Lincomycin; D002509:Cephaloridine; D003023:Cloxacillin; D008712:Methicillin; D000111:Acetylcysteine